Skip to main content
TFX
NYSE Industrial Applications And Services

Teleflex CEO Departs Amidst Strategic Shift and Lowered 2025 Revenue Guidance

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$124.65
Mkt Cap
$5.592B
52W Low
$102.58
52W High
$185.94
52W Position info
22% above low
Off High info
33% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

TFX sits 22% above its 52-week low of $102.58.

Summary

Teleflex announced the immediate departure of its CEO, Liam Kelly, and appointed an interim successor, while also lowering its full-year 2025 revenue guidance due to weaker demand and order delays.


Key Events · Executive and Board Changes · TFX

  • CEO Departs

    Liam J. Kelly departed from his roles as President and Chief Executive Officer, effective January 7, 2026.

  • Interim CEO Appointed

    Stuart A. Randle, a current member of the Board of Directors, has been appointed Interim President and Chief Executive Officer, effective January 8, 2026.

  • Board Leadership Change

    Stephen K. Klasko, the company's current lead independent director, was appointed independent Chair of the Board.

  • Revenue Guidance Lowered

    Teleflex reduced its preliminary full-year 2025 revenue guidance from $3.305-$3.320 billion to $3.270-$3.278 billion, citing softer demand for certain products and delays in purchase orders.


Analysis · TFX · Industrial Applications And Services

Teleflex announced the immediate departure of its President and CEO, Liam Kelly, effective January 7, 2026. This leadership transition is framed as aligning with the company's new phase following recent business divestitures, aiming for a more focused and higher-growth organization. Stuart Randle, a long-standing board member, has been appointed Interim President and CEO, and a search for a permanent successor is underway. Concurrently, the company lowered its preliminary full-year 2025 revenue guidance by approximately 1.16% at the midpoint, citing softer demand for certain products and delays in purchase orders. The combination of an unexpected CEO change and a revenue miss introduces significant uncertainty regarding the company's near-term performance and strategic execution. Investors will be closely watching the search for a permanent CEO and the company's ability to stabilize its revenue trajectory.

At the time of this filing, TFX was trading at $124.65 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $5.6B. The 52-week trading range was $102.58 to $185.94. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

TFX - Latest Insights

TFX
Jun 15, 2026, 5:24 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $130.09
Real-time Price: $131.05 info
Change: +$0.960 (+0.74%) info
Market Cap: $5.802B info
TFX
Jun 01, 2026, 6:35 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $127.57
Real-time Price: $131.05 info
Change: +$3.48 (+3%) info
Market Cap: $5.802B info
TFX
Jun 01, 2026, 6:35 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $127.57
Real-time Price: $131.05 info
Change: +$3.48 (+3%) info
Market Cap: $5.802B info
TFX
Jun 01, 2026, 7:59 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $128.64
Real-time Price: $131.05 info
Change: +$2.41 (+2%) info
Market Cap: $5.802B info
TFX
Jun 01, 2026, 7:50 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $128.64
Real-time Price: $131.05 info
Change: +$2.41 (+2%) info
Market Cap: $5.802B info